The Journal of Immunology, Vol 156, Issue 10 3721-3726, Copyright © 1996 by American Association of Immunologists

ARTICLES

Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen- MHC class I presentation pathway

KL Rock and K Clark
Division of Lymphocyte Biology, Dana Farber Cancer Institute, Boston, MA 02115, USA.

By conjugation of proteins to beads, Ags can be selectively targeted into the MHC class I pathway of phagocytes in vivo and can stimulate CTL responses. Because phagocytes also present particulate Ag on MHC class II molecules, we examined whether these Ags stimulated concomitant CD4 T cell immunity. Although the priming of CD4 T cells with soluble OVA required adjuvants, particulate Ag was stimulatory when injected in saline. We next examined whether CD4 T cell responses played a role in the generation of CTL to particulate Ag. At low concentrations of Ag, OVA primed CTLs in wild-type mice but not in MHC class II-deficient animals, indicating that MHC class II presentation of Ag was essential for CTL generation. These data both support a model where CD4 T cells collaborate with CTLs as part of a three-cell interaction and identify a phagocyte as the third cell in this reaction. Interestingly, injection of higher concentrations of the same Ag primed equivalent CTL responses in both wild-type and MHC class II- deficient mice. These results indicate that a key variable in determining whether CTL generation is helper cell dependent or independent is the dose of immunogen. This may explain in part why CTL responses to abundant Ags, such as viruses, tend to be helper independent, while responses to less abundant Ags, such as minor histocompatibility Ags, require T helper cells. In addition, these results also point to the potential of using particulate Ags to prime or boost responses in settings with CD4 immunodeficiency.

This article has been cited by other articles:

				A. Montecalvo, W. J. Shufesky, D. Beer Stolz, M. G. Sullivan, Z. Wang, S. J. Divito, G. D. Papworth, S. C. Watkins, P. D. Robbins, A. T. Larregina, et al. Exosomes As a Short-Range Mechanism to Spread Alloantigen between Dendritic Cells during T Cell Allorecognition J. Immunol., March 1, 2008; 180(5): 3081 - 3090. [Abstract] [Full Text] [PDF]

				J. V. Nayak, D. A. Hokey, A. Larregina, Y. He, R. D. Salter, S. C. Watkins, and L. D. Falo Jr Phagocytosis Induces Lysosome Remodeling and Regulated Presentation of Particulate Antigens by Activated Dendritic Cells J. Immunol., December 15, 2006; 177(12): 8493 - 8503. [Abstract] [Full Text] [PDF]

				R. A. Luu, K. Gurnani, R. Dudani, R. Kammara, H. van Faassen, J.-C. Sirard, L. Krishnan, and S. Sad Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium J. Immunol., August 1, 2006; 177(3): 1516 - 1525. [Abstract] [Full Text] [PDF]

				H. van Faassen, M. Saldanha, D. Gilbertson, R. Dudani, L. Krishnan, and S. Sad Reducing the Stimulation of CD8+ T Cells during Infection with Intracellular Bacteria Promotes Differentiation Primarily into a Central (CD62LhighCD44high) Subset J. Immunol., May 1, 2005; 174(9): 5341 - 5350. [Abstract] [Full Text] [PDF]

				Z. Su, J. Dannull, B. K. Yang, P. Dahm, D. Coleman, D. Yancey, S. Sichi, D. Niedzwiecki, D. Boczkowski, E. Gilboa, et al. Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer J. Immunol., March 15, 2005; 174(6): 3798 - 3807. [Abstract] [Full Text] [PDF]

				J. Kan-Mitchell, B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope J. Immunol., May 1, 2004; 172(9): 5249 - 5261. [Abstract] [Full Text] [PDF]

				L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott Archaeosomes Induce Enhanced Cytotoxic T Lymphocyte Responses to Entrapped Soluble Protein in the Absence of Interleukin 12 and Protect against Tumor Challenge Cancer Res., May 15, 2003; 63(10): 2526 - 2534. [Abstract] [Full Text] [PDF]

				S. Basta, W. Chen, J. R. Bennink, and J. W. Yewdell Inhibitory Effects of Cytomegalovirus Proteins US2 and US11 Point to Contributions from Direct Priming and Cross-Priming in Induction of Vaccinia Virus-Specific CD8+ T Cells J. Immunol., June 1, 2002; 168(11): 5403 - 5408. [Abstract] [Full Text] [PDF]

				R. Dudani, Y. Chapdelaine, H. v. Faassen, D. K. Smith, H. Shen, L. Krishnan, and S. Sad Multiple Mechanisms Compensate to Enhance Tumor-Protective CD8+ T Cell Response in the Long-Term Despite Poor CD8+ T Cell Priming Initially: Comparison Between an Acute Versus a Chronic Intracellular Bacterium Expressing a Model Antigen J. Immunol., June 1, 2002; 168(11): 5737 - 5745. [Abstract] [Full Text] [PDF]

				S. Okamoto, S. Kawabata, I. Nakagawa, and S. Hamada Administration of Superantigens Protects Mice from Lethal Listeria monocytogenes Infection by Enhancing Cytotoxic T Cells Infect. Immun., November 1, 2001; 69(11): 6633 - 6642. [Abstract] [Full Text] [PDF]

				L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott Archaeosomes Induce Long-Term CD8+ Cytotoxic T Cell Response to Entrapped Soluble Protein by the Exogenous Cytosolic Pathway, in the Absence of CD4+ T Cell Help J. Immunol., November 1, 2000; 165(9): 5177 - 5185. [Abstract] [Full Text] [PDF]

				C. Sedlik, G. Dadaglio, M. F. Saron, E. Deriaud, M. Rojas, S. I. Casal, and C. Leclerc In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity J. Virol., July 1, 2000; 74(13): 5769 - 5775. [Abstract] [Full Text]

				R. Lo-Man, J. P. M. Langeveld, E. Deriaud, M. Jehanno, M. Rojas, J.-M. Clement, R. H. Meloen, M. Hofnung, and C. Leclerc Extending the CD4+ T-Cell Epitope Specificity of the Th1 Immune Response to an Antigen Using a Salmonella enterica Serovar Typhimurium Delivery Vehicle Infect. Immun., June 1, 2000; 68(6): 3079 - 3089. [Abstract] [Full Text] [PDF]

				N. Seo, Y. Tokura, T. Nishijima, H. Hashizume, F. Furukawa, and M. Takigawa Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis PNAS, January 4, 2000; 97(1): 371 - 376. [Abstract] [Full Text] [PDF]

				S. Pion, G. J. Christianson, P. Fontaine, D. C. Roopenian, and C. Perreault Shaping the Repertoire of Cytotoxic T-Lymphocyte Responses: Explanation for the Immunodominance Effect Whereby Cytotoxic T Lymphocytes Specific for Immunodominant Antigens Prevent Recognition of Nondominant Antigens Blood, February 1, 1999; 93(3): 952 - 962. [Abstract] [Full Text] [PDF]

				A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF]

				P. Brandler, K. U. Saikh, D. Heath, A. Friedlander, and R. G. Ulrich Weak Anamnestic Responses of Inbred Mice to Yersinia F1 Genetic Vaccine Are Overcome by Boosting with F1 Polypeptide While Outbred Mice Remain Nonresponsive J. Immunol., October 15, 1998; 161(8): 4195 - 4200. [Abstract] [Full Text] [PDF]

				Z. C. Neal and G. A. Splitter Protection against Lethal Encephalomyocarditis Virus Infection in the Absence of Serum-Neutralizing Antibodies J. Virol., October 1, 1998; 72(10): 8052 - 8060. [Abstract] [Full Text] [PDF]

				L. J. Sigal, H. Reiser, and K. L. Rock The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo J. Immunol., September 15, 1998; 161(6): 2740 - 2745. [Abstract] [Full Text] [PDF]